The Liver Meeting 2019-Case Presentation Stimulated Panel Discussion/ Q&A

Video Transcription

Video Summary

The video transcript discusses three cases of post-transplant patients with NASH-related cirrhosis experiencing elevated liver enzymes. The first case involves a 66-year-old gentleman six months post-transplant showing signs of NASH recurrence. The second case is a 52-year-old female two years post-transplant with persistently elevated liver enzymes and metabolic risk factors. The third case is a 68-year-old female seven years post-transplant with advanced fibrosis. Common themes include the importance of managing metabolic factors like diabetes, dyslipidemia, and obesity, the role of liver biopsies in assessment, and the challenges of recurrent disease post-transplant. Medication optimization, lifestyle modifications, and interdisciplinary care involving endocrinology and cardiology are key in managing post-transplant NASH patients. Retransplantation considerations are necessary for patients with advanced fibrosis and cirrhosis.

Asset Caption

Presenter: Monica A. Tincopa

Keywords

post-transplant patients

NASH-related cirrhosis

elevated liver enzymes

metabolic risk factors

liver biopsies

retransplantation considerations